World of DTC Marketing

DECEMBER 17, 2021

The public has been told that pharma needs money to develop new drugs, but unfortunately, that’s a huge lie. As biopharmadive recently, “some of the biggest pharmaceutical companies, sitting on large and growing sums of cash, are funneling those funds into major share buyback programs and acquisitions of smaller biotech companies. On Thursday, Swiss drug-making giant Novartis announced plans to buy back up to $15 billion worth of its shares by end of 2023, a program it will fund wi

Pharma 209

Pharma Pharmaceutical Sales Patients 209

Pharma Marketing Network

DECEMBER 17, 2021

The pharma industry has been slower to embrace digital technologies than other less-regulated sectors but the COVID-19 pandemic has greatly changed this long-standing mindset. In 2020 and 2021, we saw pharma forced to become more flexible and open-minded than ever before. In this article, R.J. Lewis, Founder & CEO of eHealthcare Solutions and Tap Native, offers his top ten predictions for what’s ahead for pharma in 2022.

Pharma 105

Pharma Marketing Engineering Digital Media 105

Pharma Marketing Network

DECEMBER 17, 2021

Big pharma has compelling reasons to change the way business gets done. The wave of interest in sustainability follows the value chain from top-tier pharmaceutical companies to their suppliers of every size. Leaders are hard at work focusing their efforts on how to use sustainability as a platform for innovation. Step one is to assess your corporate social responsibility (CSR) policies and ensure actions are integrated across the organization.

Pharma 103

Pharma Ethics Recruitment Government 103

Pharma Marketing Network

DECEMBER 17, 2021

#1: Omnichannel engagement is the key to creating personalized customer experiences and relevancy, but it remains something of a holy grail within the pharmaceutical industry. Across several sessions at this year’s Reuters Pharma Marketing USA, leading marketers discussed why it’s been such an uphill struggle and shared possible solutions. Traditionally, pharmaceutical companies have been siloed to a degree that would be unthinkable in most other industries.

Pharma 52

Pharma Marketing Sales Physicians 52

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution